NCT01053169 - Observational Study of Prophylaxis and Treatment of Acute Perioperative Bleeding With Beriplex® P/N (Probe Study) | Biotech Hunter

Enrollment

445

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions

Coagulation Protein DisordersBlood Loss, SurgicalPerioperative Care

Interventions

BIOLOGICAL

Beriplex® P/N

Intravenous infusion, the dosage and the frequency of administration is calculated on an individual patient basis.

BIOLOGICAL

Fresh Frozen Plasma (FFP) and Beriplex® P/N

FFP is administered before Beriplex® P/N. Each treatment is given as an intravenous infusion, with the dosage of each calculated on an individual patient basis.

OTHER

Fresh Frozen Plasma

Intravenous infusion, the dosage and the frequency of administration is calculated on an individual patient basis.

Trial Locations (6)

Unknown

Royal Blackburn Hospital, Blackburn

Royal Free Hospital, London

Derriford Hospital, Plymouth

Southhampton General Hospital, Southhampton

FY3 8NR

Blackpool, Blackpool

CB23 3RE

Addenbrokes, Cambridge